ANIP

ANI Pharmaceuticals, Inc.

HealthcareDrug Manufacturers - Specialty & GenericUSUSDPeers →

$79.49

LiveJun 18, 2026

AI Brief

Market cap

$1.81B

52w range

62.61 – 99.50

P / E

—

EPS · FY 2025

$3.32

Volume

317.09K

Revenue · FY 2025

$883.37M

+43.78% YoY

Overview Fundamentals Valuation Market Ownership & flow Narrative & AI

Financials Enterprise value Ratios Multiples Segments Profile Management

Explain this page

Arphra AIPlain-English read on ANI Pharmaceuticals, Inc.’s valuation

Enterprise value

$1.82B

Market cap

$1.81B

Net debt

$39.61M

Total debt

$325.2M

Cash & ST inv.

$285.59M

Capital structure

· balance sheet · 2025-12-31

Enterprise-value bridge

Equity 99%

Share of enterprise value funded by equity vs net debt.

Market capitalisation$1.81B

+ Total debt+$325.2M

− Cash & short-term investments−$285.59M

= Enterprise value$1.82B

Valuation

· key metrics · TTM

EV multiples

EV / EBITDA7.8×

EV / Sales2.0×

EV / FCF11.4×

Net debt / EBITDA0.1×

Debt / Equity—

AI read · capital structure

Arphra AIPlain-English read on the EV build & leverage